NCT06893835View on ClinicalTrials.gov

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

June 30, 2025

Conditions
Infection in ICU
Interventions
DRUG

Colistimethate Sodium

compare the clinical outcomes and safety between colistin and tigecycline for multi-drug-resistant gram-negative bacteria.

DRUG

Tigecycline

compare the clinical outcomes and safety between colistin and tigecycline for multi-drug-resistant gram-negative bacteria.

Trial Locations (1)

Unknown

Pharmacy, Cairo

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT06893835 - Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline | Biotech Hunter | Biotech Hunter